To amend title IV of the Public Health Service Act to prohibit sale or transactions relating to human fetal tissue.

Bill 119 HR 727, also known as the "Human Fetal Tissue Prohibition Act," aims to make changes to title IV of the Public Health Service Act in order to prevent the sale or transactions involving human fetal tissue. The bill seeks to prohibit any individual or entity from knowingly acquiring, receiving, or transferring fetal tissue obtained through an abortion for valuable consideration.

The legislation is designed to address concerns surrounding the ethical implications of the sale and use of human fetal tissue. Supporters of the bill argue that the practice of selling fetal tissue is morally wrong and should be prohibited in order to protect the dignity of human life.

If passed, the bill would impose penalties on individuals or entities found to be in violation of the prohibition, including fines and potential imprisonment. The legislation also includes provisions for the enforcement of the prohibition and the reporting of violations to the appropriate authorities. Overall, Bill 119 HR 727 represents a significant effort to regulate the use of human fetal tissue and prevent its exploitation for financial gain. The bill has garnered support from those who believe in the sanctity of human life and the need to uphold ethical standards in medical research and practice.